“The impact of alopecia areata extends beyond cosmetic concerns and carries a considerable psychosocial burden for patients,” stated lead author of the publication, Natasha Mesinkovska, MD ...

The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary care. Br J Dermatol . 2022;187(1):73-81. doi:10.1111/bjd.21055 3.

Patients with alopecia areata (AA) face significant out-of-pocket costs for treatments, despite many having limited efficacy. Prior research estimated the annual out-of-pocket AA treatment cost to ...

Children of various racial and ethnic minority groups have a higher prevalence of alopecia areata than non-Hispanic White children.

Alopecia areata can affect your emotional well-being and your quality of life. Some people even think about suicide. It's normal to be sad or angry when you have a condition that affects your self ...

At the time of alopecia areata diagnosis, 30.9% of patients had psychiatric comorbidities compared with 26.8% of unmatched controls without alopecia areata (P<0.001), while 16.1% versus 8.9% ...

Alopecia areata exemplifies such a condition, owing to its substantial disease burden and its often devastating effects on the patient's quality of life and self-esteem. 1,2 Although alopecia ...

Hair loss associated with alopecia areata not only affects the scalp area, but also the beard, eyebrows, eyelashes, and armpits. For many, hair can represent more than just societal standards.

People with autoimmune skin diseases had significantly better cancer survival outcomes than others. Survival benefits were ...

FDA approves first treatment for alopecia 02:26. LEXINGTON - The FDA just approved the first treatment of alopecia areata or baldness. The drug known as Olumiant from Eli Lilly works by blocking ...

Concert Pharmaceuticals, Inc. today announced that the Journal of Investigative Dermatology published results from a survey designed to understand the burden and everyday experience for patients ...

At the time of alopecia areata diagnosis, 30.9% of patients had psychiatric comorbidities compared with 26.8% of unmatched controls without alopecia areata (P<0.001), while 16.1% versus 8.9% ...